The DOI matches its Crossref record.
A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjects
Abstract
Background: Rabeprazole (LY307640, E3810) is a new, potent, proton pump inhibitor. A single daily 20 mg dose significantly decreases 24‐h intragastric acidity. There are no data currently available directly comparing the effect of rabeprazole on 24‐h acidity with established proton pump inhibitors. Aim: To compare the effects of rabeprazole 20 mg o.m. and omeprazole 20 mg o.m. on 24‐h intragastric acidity and plasma gastrin concentration in a randomized, double‐blind, placebo‐controlled trial, in healthy H. pylori‐negative subjects. Methods: Twenty‐four healthy male volunteers, negative for H. pylori infection by serology and 13 C‐urea breath test, were studied on the 1st and 8th day of dosing with either placebo, rabeprazole 20 mg or omeprazole 20 mg, once each morning, in a crossover fashion. On days 1 and 8, hourly intragastric acidity was measured by gastric aspiration for 24 h from 08.00 hours. On day 8, plasma gastrin concentrations were also measured hourly from 08.00 to 24.00 hours, then every 2 h thereafter. Results: A single dose of both rabeprazole and omeprazole significantly decreased 24‐h intragastric acidity compared with placebo. The 24‐h acidity on day 1 was significantly decreased for rabeprazole compared with omeprazole (331 vs. 640 mmol.h/L, P < 0.001), resulting in a significantly higher median 24‐h intragastric pH and longer times at which intragastric pH was> 3 and> 4. On day 8 of dosing, the decrease in 24‐h intragastric acidity was greater with rabeprazole than with omeprazole, but the difference was not statistically significant (160 vs. 218 mmol.h/L, P = 0.1). However, 24‐h plasma gastrin concentration (1687 vs. 1085 pmol.h/L, P < 0.01) and percentage time that intragastric pH was> 3 (69 vs. 59%, P = 0.008) and> 4 (60 vs. 51%, P = 0.03) were significantly greater. Conclusions: Rabeprazole 20 mg once daily has a significantly faster onset of antisecretory activity than omeprazole 20 mg once daily. After 8 days the differences in intragastric pH > 3 and> 4 holding times persisted, but there was no significant difference in 24‐h acidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Stedman, C. A. M., & Barclay, M. L. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00788.x · Cited by 317
Safety of the long-term use of proton pump inhibitors
Thomson, A. B. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i19.2323 · Cited by 315
Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH
Kirchheiner, J., Glatt, S., Fuhr, U., Klotz, U., Meineke, I., Seufferlein, T., & Brockmöller, J. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0576-5 · Cited by 277
Influence of CYP2C19 Pharmacogenetic Polymorphism on Proton Pump Inhibitor-based Therapies
Furuta, T., Shirai, N., Sugimoto, M., Nakamura, A., Hishida, A., & Ishizaki, T. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.153 · Cited by 257
Huang, J.-Q., & Hunt, R. H. (2001) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2001.0184 · Cited by 127
Metadata
- Authors
- Williams, Sercombe, Hamilton, & Pounder
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1998-11
- Volume
- 12
- Issue
- 11
- Pages
- 1079-1089
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2013080155
- Cited by
- 168
- References
- 0
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. https://app.cochat.ai/papers/10.1046/j.1365-2036.1998.00418.x
- The paper
- Williams, Sercombe, Hamilton, & Pounder. (1998). A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1998.00418.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.